The emerging antimicrobial resistance crisis during the COVID-19 surge in China
- PMID: 36780910
- PMCID: PMC9917447
- DOI: 10.1016/S2666-5247(23)00038-1
The emerging antimicrobial resistance crisis during the COVID-19 surge in China
Conflict of interest statement
We declare no competing interests. ZW and MY contributed equally. This work was partially supported by AIR@InnoHK administered by Innovation and Technology Commission.
Comment in
-
Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency.Lancet Microbe. 2023 May;4(5):e293. doi: 10.1016/S2666-5247(23)00061-7. Epub 2023 Mar 15. Lancet Microbe. 2023. PMID: 36933564 Free PMC article. No abstract available.
References
-
- Zhao H, Wei L, Li H, et al. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis. 2021;21:847–857. - PubMed
-
- Chang J, Xu S, Zhu S, et al. Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study. Lancet Infect Dis. 2019;19:1345–1354. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
